# Robert A. Riesenberg, M.D. – FDA Inspection, Jun 17, 2019

Source: https://www.keypedia.com/records/fda_inspections/robert-a-riesenberg-md/37e2749a-6375-494b-a54d-dd107ee4fd5b
Source feed: FDA_Inspections

> FDA inspection 1094120 of Robert A. Riesenberg, M.D., June 17, 2019. Classification: No Action Indicated (NAI). 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1094120
- Company Name: Robert A. Riesenberg, M.D.
- Inspection Date: 2019-06-17
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1335296 - 2026-09-03
- FDA Inspection 1169440 - 2022-05-03
- FDA Inspection 1145517 - 2021-06-24
- FDA Inspection 1039883 - 2018-01-19
- FDA Inspection 914123 - 2015-02-02

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/vanessa-e-coulter/add8407c-0df8-43ed-9f5a-8063880ce638)

Company: https://www.keypedia.com/companies/robert-a-riesenberg-md/99a54e10-48d4-476a-a2bd-7c81e44ab698

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c